Exact Sciences Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Exact Sciences Corp.
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Exact Sciences Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Exact Sciences Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Exact Sciences Corp. is EXAS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Exact Sciences Corp. has its primary listing on NASDAQ (Small cap). You can trade Exact Sciences Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Exact Sciences Corp. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Exact Sciences Corp. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Exact Sciences Corp..